A 28-year-old Middle Eastern man develops severe motor disturbances, including muscle rigidity, tremors, a parkinsonian gait, and involuntary, jerky limb movements, following the administration of a 3 ...

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a ...

Background: Second-generation antipsychotics (SGAs) are thought to have a lower likelihood of inducing extrapyramidal symptoms (EPS) than are first-generation antipsychotics (FGAs). Clinical ...

Atypical antipsychotics are also known for their reduced risk of causing movement disorders like tardive dyskinesia and ...

and aripiprazole are atypical antipsychotic drugs. With the discovery of clozapine in 1959, it became evident that this drug was less likely to produce extrapyramidal effects (physical symptoms ...

antipsychotic, and anti-nausea medications) but drugs with other mechanisms of action can also cause tardive syndrome. This group of disorders is often referred to in the literature as “extrapyramidal ...

Atypical antipsychotic drugs are less prone to induce extrapyramidal side effects than typical antipsychotics. Distinct pharmacologic profiles, especially actions on 5-hydroxytryptamine (5-HT ...

The US Food and Drug Administration (FDA) is poised to regulate a "potential first-in-class antipsychotic", known as KarXT, said Medscape. About one in 300 people worldwide are affected by ...

First-generation antipsychotics, such as haloperidol (0.04) and fluphenazine (0.15), ranked low in cognitive performance, as did clozapine, a second-generation antipsychotic often used for ...

antipsychotics. They are less likely to cause involuntary movements (extrapyramidal effects), but many may cause weight gain and increased cholesterol. However, these effects were not common with ...